Leishmaniasis in The Gambia. I. A case of cutaneous leishmaniasis and a case of visceral leishmaniasis

Conteh, Sorie; Desjeux, P.

doi:10.1016/0035-9203(83)90147-5

Cited by 9 publications

(4 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Most of these cases occurred more than ten years ago: one Togolese case was diagnosed in Lama-Kara (Northern region) in 1994; and in Nigeria suspected cases have been reported between 1936 and 1947 [14] and 60 cases between 2005 and 2012 [3]. The Gambian cases were reported in 1949, 1980, and 1982 near Fajara [7, 15, 16]. A case of VL in a European boy in Upper Volta (now called Burkina Faso) was described in 1978 [17].…”

Section: Resultsmentioning

confidence: 99%

Visceral Leishmaniasis in West Africa: Clinical Characteristics, Vectors, and Reservoirs

Koné

Niare

Piarroux

et al. 2019

Journal of Parasitology Research

View full text Add to dashboard Cite

Visceral leishmaniasis (VL) is the most serious form of human leishmaniasis. VL is understudied in West Africa. The increasing number of patients at-risk, including persons living with HIV and other chronic immunosuppressive diseases, and likely underreporting of VL related to diagnostic challenges advocate for review of existing data to understand VL regional epidemiology. Our review aims to describe the clinical characteristics and epidemiology of Human VL (HVL) in West Africa. We conducted a literature search to identify peer-reviewed articles and grey literature sources using the search terms “Visceral leishmaniasis West Africa”, “Leishmania donovani West Africa”; and “Leishmania infantum West Africa”. Thirty published articles report HVL from seven countries, including The Gambia, Niger, Nigeria, Ivory Coast, Togo, Burkina Faso, and Guinea Bissau. Three countries report cases of Canine Visceral Leishmaniasis (CVL), including The Gambia, Senegal, and Burkina Faso. Niger, Nigeria, and Ivory Coast report the greatest number of HVL cases. As VL is present in West Africa, active surveillance, increased diagnostic capacity, and studies of vectors and reservoirs are essential to better understand VL epidemiology in the region.

show abstract

Section: Resultsmentioning

confidence: 99%

Visceral Leishmaniasis in West Africa: Clinical Characteristics, Vectors, and Reservoirs

Koné

Niare

Piarroux

et al. 2019

Journal of Parasitology Research

View full text Add to dashboard Cite

show abstract

“…The CL is found in Senegal (4) and L. major has been identified in a number of non-primate mammals (5). Case reports of CL exist from The Gambia (6, 7). …”

Section: Cutaneous Leishmaniasis In West Africamentioning

confidence: 99%

An outbreak of suspected cutaneous leishmaniasis in Ghana: lessons learnt and preparation for future outbreaks

Kweku

Odoom

Puplampu

et al. 2011

Global Health Action

View full text Add to dashboard Cite

Human cutaneous leishmaniasis (CL) has previously been reported in West Africa, but more recently, sporadic reports of CL have increased. Leishmania major has been identified from Mauritania, Senegal, Mali, and Burkina Faso. Three zymodemes (MON-26, MON-117, and MON-74, the most frequent) have been found. The geographic range of leishmaniasis is limited by the sand fly vector, its feeding preferences, and its capacity to support internal development of specific species of Leishmania. The risk of acquiring CL has been reported to increase considerably with human activity and epidemics of CL have been associated with deforestation, road construction, wars, or other activities where humans intrude the habitat of the vector. In the Ho Municipality in the Volta Region of Ghana, a localised outbreak of skin ulcers, possibly CL, was noted in 2003 without any such documented activity. This outbreak was consistent with CL as evidenced using various methods including parasite identification, albeit, in a small number of patients with ulcers.This paper reports the outbreak in Ghana. The report does not address a single planned study but rather a compilation of data from a number of ad-hoc investigations in response to the outbreak plus observations and findings made by the authors. It acknowledges that a number of the observations need to be further clarified. What is the detailed epidemiology of the disease? What sparked the epidemic? Can it happen again? What was the causative agent of the disease, L. major or some other Leishmania spp.? What were the main vectors and animal reservoirs? What are the consequences for surveillance of the disease and the prevention of its reoccurrence when the communities see a self-healing disease and may not think it is important?

show abstract

“…The disease however, is uncommon. Visceral leishmaniasis cases have been reported from Togo (De Campos et al 1979), Burkina Faso (Andre et al 1978) and the Gambia (Conteh and Desjeux, 1983;Greenwood et al 1984).…”

Section: Leishmaniasis In West Africamentioning

confidence: 99%

Leishmaniasis in northern and western Africa: a review

Kimutai¹,

Ngure²,

Tonui³

et al. 2010

African Journal of Infectious Diseases

View full text Add to dashboard Cite

Leishmaniasis, one of the highly neglected diseases is currently a significant health problem in northern Africa with a rising concern in western Africa because of co-infection with the Human Immunodeficiency Virus (HIV). In this review, we present a summarized analysis of the epidemiology, infective species, parasites reservoirs, diagnosis, treatment and control measures of leishmaniasis in northern and western Africa region. In northern Africa, the disease is prevalent in Morocco, Algeria, Tunisia, Egypt and Libya. Comparatively, there are low prevalence rates of the disease in West African countries including Cameroon, Ghana, Burkina Faso, Niger, Mali, Nigeria and Senegal. In North Africa, visceral leishmaniasis (VL) is caused by L. infantum and transmitted by Phlebotomus perniciosus and P. longicuspis. On the other hand, cutaneous leishmaniasis (CL) is mainly caused by L. major and transmitted by P. papatasi, P. duboscqi and P. pedifer with L. infantum and L. tropica causing lower incidences of the disease. Notably, Algeria is one of the countries that constitute 90% of CL cases worldwide. In Western Africa; CL is caused by L. major while VL is caused by L. donovani. In these regions, zoonotic and anthroponotic cutaneous and visceral leishmaniasis is a health problem that should be addressed urgently.

show abstract

Leishmaniasis in The Gambia. I. A case of cutaneous leishmaniasis and a case of visceral leishmaniasis

Cited by 9 publications

References 6 publications

Visceral Leishmaniasis in West Africa: Clinical Characteristics, Vectors, and Reservoirs

Visceral Leishmaniasis in West Africa: Clinical Characteristics, Vectors, and Reservoirs

An outbreak of suspected cutaneous leishmaniasis in Ghana: lessons learnt and preparation for future outbreaks

Leishmaniasis in northern and western Africa: a review

Contact Info

Product

Resources

About